Reports say McKesson and Clayton Dubilier & Rice are nearing a deal to acquire Option Care Health, which could benefit its owners. The report gives no terms and does not say a deal is complete, so the outcome is uncertain.
A buyer could pay to take over Option Care Health, which may benefit its owners. The report says the parties are nearing a deal, not that they have completed one. It gives no deal terms, so the possible benefit is not certain.
Vaxcyte announced results from an adult trial, but this story does not say what the results showed. Without those findings, it does not establish a change in the company's outlook.
Constellation Brands is due to report results after the market closes, and analysts expect $3.57 per share in profit on $2.54 billion in sales. Those are estimates, not new company results, so the story does not change its outlook.
Follow Option Care Health (OPCH) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for OPCH